Factors related with the progression of chronic kidney disease

Nefrologia

Volumn 33, Issue 5, 2013, Pages 685-691

  Yuste, Claudia ^a   Barraca, Daniel ^a   Aragoncillo Sauco, Inés ^a   Vega Martínez, Almudena ^a   Abad, Soraya ^a   Verdalles Guzmán, Úrsula ^a   Ruiz Caro, Caridad ^a   Ampuero, Jara ^a   López Gómez, Juan M ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Bone metabolism; Chronic kidne disease; Parathyroid hormone (PTH); Progression of renal insufficiency; Proteinuria; Serum phosphate

Indexed keywords

ANTIANEMIC AGENT; CALCIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE; PHOSPHORUS; URIC ACID;

AGED; ANEMIA; ARTICLE; BLOOD; CHRONIC DISEASE; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROTEINURIA; RENAL OSTEODYSTROPHY; RETROSPECTIVE STUDY; RISK FACTOR; URINE;

AGED; ANEMIA; CALCIUM; CHRONIC DISEASE; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HEMATINICS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; KIDNEY DISEASES; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; PROTEINURIA; RENAL OSTEODYSTROPHY; RETROSPECTIVE STUDIES; RISK FACTORS; URIC ACID;

EID: 84885353610     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2013.May.11900     Document Type: Article

References (31)

1. Otero A, Gayoso P, Garcia F, de Francisco AL; EPIRCE study group. Epidemiology of chronic renal disease in the Galician population: results of the pilot Spanish EPIRCE study. Kidney Int Suppl 2005;(99):S16-9.
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-69.
3. Lucove J, Vupputuri S, Heiss G, North K, Russell M. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis 2008;51(1):21-8.
4. Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int 2006;70:1694-705.
5. Kronenberg F. Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol 2009;5:677-89.
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70.
8. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985;27:58-65.
9. Zitt E, Lamina C, Sturm G, Knoll F, Lins F, Freistätter O, et al. Interaction of time-varying albumin and phosphorus on mortality in incident dialysis patients. Clin J Am Soc Nephrol 2011;6(11):2650-6.
10. Kuro OM. Phosphate and Klotho. Kidney Int Suppl 2011;121:S20- S23.
11. Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 2006;1:825-31.
12. Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, van Manen JG, et al.; PREPARE study group. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 2007;22:2909-16.
13. Lorenzo V. Similar renal decline in diabetic and non-diabetic patients with comparable levels of albuminuria. Nephrol Dial Transplant 2010;25:835-41.
14. Zoccali C, Ruggenenti P, Perna A, Leonardis D, Tripepi R, Tripepi G, et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol 2011;22:1923-30.
15. Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, et al.; MMKD Study Group. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2007;18(9): 2600-8.
16. Kendrick J, Cheung AK, Kaufman J, Greene T, Roberts W, Smits G, et al., and the HOST investigators. FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 2011;22:1913-22.
17. Haruna Y, Kashihara N, Satoh M, Tomita N, Namikoshi T, Sasaki T, et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci U S A 2007;104:2331-6.
18. Remuzzi G, Ruggenenti P, Perico N. Chronic renal diseases: renal protective benefits of renin-angiotensin system inhibition. Ann Intern Med 2002;136: 604-15.
19. Lorenzo V. Fósforo y supervivencia. Nefrologia 2009;29(Suppl 5):6-9.
20. Zeeuw D, Remuzzi G, Parking H-H, Keane WF, Zhang Z, Shahinfar S, et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL. Kidney Int 2004;65:2309-20.
21. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994;330:877-84.
22. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47.
23. El-Ghoul B, Elie C, Sqalli T, Jungers P, Daudon M, Grünfeld JP, et al. Nonprogressive kidney dysfunction and outcomes in older adults with chronic kidney disease. J Am Geriatr Soc 2009;57:2217-23.
24. Van Biesen W, Lameire N, Veys N, Vanderhaegen B. From curing to caring: one character change makes a world of difference. Issues related to withholding/withdrawing renal replacement therapy (RRT) from patients with important co-morbidities. Nephrol Dial Transplant 2004;19:536-40.
25. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 2007;22:1955-62.
26. Taal MW, Brenner BM. Renal risk scores: Progress and prospects. Kidney Int 2008;73:1216-9.
27. Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis 1996;27:652-63.
28. USRDS 2007 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2007, 84.
29. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000;11:319-29.
30. Xu R, Zhang LX, Zhang PH, Wang F, Zuo L, Wang HY. Gender differences in age-related decline in glomerular filtration rates in healthy people and chronic kidney disease patients. BMC Nephrology 2010;11:20.
31. Keane WF, Zhang Z, Lyle PA, Cooper ME, de Zeeuw D, Grunfeld JP; RENAAL Study Investigators. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: The RENAAL Study. Clin J Am Soc Nephrol 2006;1:761-7.